OSE Immunotherapeutics Presents New “Cis-Demasking” Bispecific Technology for the Design of Cytokine Drugs with Improved Therapeutic Index

OSE ImmunotherapeuticsNANTES, France, October 17, 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced it will be...

KeyShot announces their Product Design-to-Market Suite and new SaaS category to help product companies leverage 3D to save millions and propel product innovation |

COSTA MESA, Calif., Oct. 16, 2024 /PRNewswire/ -- KeyShot announced a significant expansion of its company strategy, pioneering a new SaaS...